MX2007007911A - Composicion farmaceutica granular estable de solifenacina o su sal. - Google Patents

Composicion farmaceutica granular estable de solifenacina o su sal.

Info

Publication number
MX2007007911A
MX2007007911A MX2007007911A MX2007007911A MX2007007911A MX 2007007911 A MX2007007911 A MX 2007007911A MX 2007007911 A MX2007007911 A MX 2007007911A MX 2007007911 A MX2007007911 A MX 2007007911A MX 2007007911 A MX2007007911 A MX 2007007911A
Authority
MX
Mexico
Prior art keywords
solifenacin
salt
pharmaceutical composition
granular pharmaceutical
granular
Prior art date
Application number
MX2007007911A
Other languages
English (en)
Inventor
Hiroyuki Umejima
Hiroshi Ohi
Katsumi Saito
Yuko Taketani
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40283425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2007007911(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Priority claimed from PCT/JP2005/023771 external-priority patent/WO2006070735A1/ja
Publication of MX2007007911A publication Critical patent/MX2007007911A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se proporciona una composicion farmaceutica granular estable de solifenacina o su sal que en la aplicacion de las preparaciones de solifenacina o su sal en los campos clinicos, tiene una forma esferica adecuada para el revestimiento, que es capaz de inhibir la descomposicion por el envejecimiento a modo de ser estable. En particular, se proporciona una composicion farmaceutica granular producida mediante la produccion de una composicion granular de solifenacina, utilizando un agente aglutinante de un Tg o pf de <174 degree C. Se proporciona una composicion granular de solifenacina o su sal, ademas se estabiliza mediante la adicion de un tratamiento de promocion de la cristalizacion despues de la produccion de una composicion farmaceutica granular.
MX2007007911A 2004-12-27 2005-12-26 Composicion farmaceutica granular estable de solifenacina o su sal. MX2007007911A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63838804P 2004-12-27 2004-12-27
JP2005085968 2005-03-24
PCT/JP2005/023771 WO2006070735A1 (ja) 2004-12-27 2005-12-26 ソリフェナシンまたはその塩の安定な粒子状医薬組成物

Publications (1)

Publication Number Publication Date
MX2007007911A true MX2007007911A (es) 2007-08-20

Family

ID=40283425

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007007911A MX2007007911A (es) 2004-12-27 2005-12-26 Composicion farmaceutica granular estable de solifenacina o su sal.

Country Status (10)

Country Link
JP (1) JP4636445B2 (es)
BG (1) BG1677U1 (es)
BR (1) BRPI0519270A2 (es)
CZ (1) CZ23089U1 (es)
ES (1) ES2387571T3 (es)
IL (1) IL183877A0 (es)
MX (1) MX2007007911A (es)
RU (1) RU2397767C2 (es)
SK (1) SK6196Y1 (es)
TW (1) TW200635590A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
EP1552825A4 (en) * 2002-06-07 2009-11-25 Astellas Pharma Inc THERAPEUTIC AGENT FOR THE TREATMENT OF VESIC HYPERACTIVITY
JP4523265B2 (ja) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤

Also Published As

Publication number Publication date
TW200635590A (en) 2006-10-16
JPWO2006070735A1 (ja) 2008-06-12
RU2397767C2 (ru) 2010-08-27
RU2007128815A (ru) 2009-02-10
SK6196Y1 (sk) 2012-08-06
ES2387571T3 (es) 2012-09-26
BRPI0519270A2 (pt) 2009-01-06
JP4636445B2 (ja) 2011-02-23
IL183877A0 (en) 2007-10-31
BG1677U1 (bg) 2013-04-30
CZ23089U1 (cs) 2011-12-19
SK50212011U1 (sk) 2012-01-04

Similar Documents

Publication Publication Date Title
EP1728791A4 (en) COMPOSITIONS FOR SOLID PHARMACEUTICAL PREPARATION OF SOLIFENACIN OR BZW. A SALT OF IT
GEP201706780B (en) Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
MY147262A (en) 1-aza-bicyclo[3.3.1]nonanes
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
WO2007065664A3 (en) Pyrazolo[1,5-a]pyridine-3-carboxylic acids as ephb and vegfr2 kinase inhibitors
NZ591712A (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
AU2018236805B2 (en) Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives
MY147488A (en) Substituted 7-azaindazoles, compositions containing them, production process and use
WO2007025709A3 (en) Organic compounds
WO2008130320A3 (en) Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
WO2008131149A3 (en) Crystal forms of saxagliptin and processes for preparing same
MX2007008237A (es) Compuestos de piridina novedosos.
WO2009098715A3 (en) Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
WO2006117211A3 (en) Urea derivatives methods for their manufacture and uses thereof
TW200745136A (en) 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives
TW200833670A (en) Novel compounds 569
WO2006124413A3 (en) Methods for treating drug resistant cancer
PT1730144E (pt) Compostos de 1,4,8-triaza-espiro[4.5]decan-2-ona substituídos
PL1869038T3 (pl) Podstawione pochodne 5,6,7,8-tetrahydro-imidazo[1,2-a]pirydyn-2-yloaminy i ich zastosowanie do wytwarzania środków leczniczych
MXPA04004373A (es) Compuestos heterociclicos condensados con fenilo azabiciclo para el tratamiento de enfermedades.
TW200626581A (en) Compounds, compositions containing them, preparation thereof and uses thereof
WO2003018568A3 (en) Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
MX2007007911A (es) Composicion farmaceutica granular estable de solifenacina o su sal.
WO2008078453A1 (ja) 血小板産生促進因子及びその利用

Legal Events

Date Code Title Description
FG Grant or registration